Suven Life Sciences secures four product patents; stock up
Shares of Suven Life Sciences gained momentum after the company secured four product patents, two each from New Zealand and Eurasia corresponding to the New Chemical Entities for treatment of disorders associated with Neurodegenerative diseases.
By ET Bureau |
MUMBAI: Shares of Suven Life Sciences gained momentum after the company secured four product patents, two each from New Zealand and Eurasia corresponding to the New Chemical Entities for treatment of disorders associated with Neurodegenerative diseases. These patents are valid until 2022 and 2025 respectively.
The stock was at Rs 26.10, up 8.98 per cent on the BSE. It touched a high of Rs 26.70 and low of Rs 24.25 on volume of 5.29 lakh shares.
The stock was at Rs 26.10, up 8.98 per cent on the BSE. It touched a high of Rs 26.70 and low of Rs 24.25 on volume of 5.29 lakh shares.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
